When you enter multiple keywords separated by space, your search will contain results that match any of the keywords (OR search).
  • 8 Hits
  • Search Condition : Filter (MeSH = Bile Duct Neoplasms / drug therapy)
Species Resource
Human and Animal Cells RBE(RCB1292) , YSCCC(RCB1549) Survival pathway of cholangiocarcinoma via AKT/mTOR signaling to escape RAF/MEK/ERK pathway inhibition by sorafenib.
Human and Animal Cells TFK-1(RCB2537) Influence of mTOR-inhibitors and mycophenolic acid on human cholangiocellular carcinoma and cancer associated fibroblasts.
Human and Animal Cells Establishment of six new human biliary tract carcinoma cell lines and identification of MAGEH1 as a candidate biomarker for predicting the efficacy of gemcitabine treatment.
Human and Animal Cells Epigenetic therapy with the histone methyltransferase EZH2 inhibitor 3-deazaneplanocin A inhibits the growth of cholangiocarcinoma cells.
Human and Animal Cells Fibroblast growth factor receptor 4 promotes progression and correlates to poor prognosis in cholangiocarcinoma.
Human and Animal Cells Dual blockade of the Hedgehog and ERK1/2 pathways coordinately decreases proliferation and survival of cholangiocarcinoma cells.
Human and Animal Cells RBE(RCB1292) Isocitrate dehydrogenase 1 mutation sensitizes intrahepatic cholangiocarcinoma to the BET inhibitor JQ1.
Human and Animal Cells HuCCT1(RCB1960) , RBE(RCB1292) Genomic perturbations reveal distinct regulatory networks in intrahepatic cholangiocarcinoma.